A Five-miRNA Panel Identified From a Multicentric Case–control Study Serves as a Novel Diagnostic Tool for Ethnically Diverse Non-small-cell Lung Cancer Patients
Cheng Wang(Qingdao University), Chen‐Yu Zhang(Central South University), Yi Shen(Nanjing General Hospital of Nanjing Military Command), Sidi Chen(Yale Cancer Center), Ke Zen(Nanjing Drum Tower Hospital), Xi Chen(Sichuan University), Nan Wang(Soochow University), Xiangdong Wang(Shandong University), Junjun Wang(Nanjing General Hospital of Nanjing Military Command), Yanni Zhang(Jiangsu University), Anh Van Le(Ortho Clinical Diagnostics (United States)), Meng Ding(Chinese Academy of Sciences), Rafael W. Soto‐Gil(Ortho Clinical Diagnostics (United States)), Mingde Xia, Wanjian Gu(Nanjing University of Chinese Medicine)
Cited by 85
Related Papers
Exogenous plant MIR168a specifically targets mammalian LDLRAP1: evidence of cross-kingdom regulation by microRNA
|Cell Research|2011|1.2k
High-content CRISPR screening
|Nature Reviews Methods Primers|2022|572